[Form 3] Galmed Pharmaceuticals Ltd. Initial Statement of Beneficial Ownership
Rhea-AI Filing Summary
Galmed Pharmaceuticals Ltd. director and CEO Baharaff Allen has filed an initial statement of holdings, detailing his equity position in the company. He directly owns 103,047 ordinary shares and has an additional 18 ordinary shares beneficially owned through his spouse.
He also holds options to purchase ordinary shares, including grants exercisable for 1,222 shares at exercise prices of 599.4000, 921.6000, and 2080.8000 per share, expiring between 2028 and 2030, plus options over 1,805 shares at an exercise price of 0.0020 per share expiring in 2028.
In addition, he reports restricted share units, including 8,889 units that vest on August 7, 2026, 96,666 units vesting in four equal installments between May 12, 2026 and November 12, 2027, and 100,000 units vesting between August 26, 2026 and August 26, 2028, all subject to his continued service. The filing reflects holdings only and does not show new buy or sell transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Footnotes (1)
- Ordinary shares beneficially owned by Reporting Person's spouse. These restricted share units vest on August 7, 2026, subject to the Reporting Person's continued service. These restricted share units vest in four equal installments on each of May 12, 2026, November 12, 2026, May 12, 2027 and November 12, 2027, subject to the Reporting Person's continued service. These restricted share units vest in accordance with the following vesting schedule: 1/3 shall vest on August 26, 2026 and the remaining portion shall vest in four equal installments on each of February 26, 2027, August 26, 2027, February 26, 2028 and August 26, 2028, subject to the Reporting Person's continued service.
